HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Recall Of Benzene-Tainted Sunscreens Lends Weight To Valisure Claims, Triggers Class Action

Executive Summary

J&J says the recall decision was made out of an abundance of caution, maintaining that daily exposure to benzene at levels detected in J&J sunscreen products “would not be expected to cause adverse health consequences.”

You may also be interested in...



US Rep. Schakowsky Wants Cosmetic Supply Chain Transparency; Benzene In Sunscreen Cited

Cosmetic ingredient and raw material suppliers would be required to share toxicity and safety data with brand owners, along with certificates of analysis and contaminant testing reports, under the Cosmetic Supply Chain Transparency Act of 2021. The bill is part of a proposed Safer Beauty package introduced in the US House on 29 July by Jan Schakowsky, D-IL, and colleagues.

Second-Quarter Consumer Health Results Bring J&J Relief From Year-Ago Sales Plummet

In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.

J&J’s Rumored Plan To End Talc Litigation Through Bankruptcy ‘Contemptible’ – Plaintiffs’ Attorneys

Plaintiffs’ attorneys blast J&J for reportedly considering weaseling out of its fiscal responsibilities by reorganizing its business away from talc liabilities, which could draw out tort proceedings and significantly reduce plaintiff awards, they suggest.

Related Content

Topics

UsernamePublicRestriction

Register

RS151557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel